Keyword: Janssen

News

Johnson & Johnson Receives Two Cancer Drug Approvals

11.08.2023 -

The US FDA approved Akeega and Talvey late last week. Phase 3 trials validated Akeega's use in the treatment of patients with BRCA-positive prostate cancer. Talvey is...

News

Janssen Sciences Ireland is Overall Winner of ISPE’s 2021 Facility of the Year Awards

03.11.2021 -

The International Society for Pharmaceutical Engineering (ISPE) has announced Janssen Sciences Ireland as the 2021 Facility of the Year Awards (FOYA) Overall Winner.

Research & Innovation

Artificial Intelligence for New Drug Design

16.09.2021 -

Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.

Chemistry & Life Sciences

Innovation and Creativity in the Pharmaceutical Industry

30.04.2021 -

The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special...

Plant Construction & Process Technology

Technology and Innovation in the Pharmaceutical Industry

14.04.2020 - Established in 2004 by the International Society for Pharmaceutical Engineering (ISPE), the Facility of the Year Awards (FOYA) recognize innovation and creativity in manufacturing...

News

Janssen and MeiraGTx Link on Optical Gene Therapy

06.02.2019 - Janssen, the pharmaceuticals arm of Johnson & Johnson, is once again collaborating with US clinical-stage gene therapy company MeiraGTx to develop and commercialize treatments for...

News

J&J Janssen arm to Buy Benevir Biopharm

10.05.2018 - BeneVir Biopharm, a privately-held biotechnology company in the life science portfolio of the HC2 holding, will be bought by Janssen Biotech, a subsidiary of Johnson & Johnson...

News

Janssen and Theravance in IBD Drug Pact

12.02.2018 - Janssen Biotech, part of pharma and consumer goods giant Johnson & Johnson, has entered into a global development and commercialization agreement with Theravance Biopharma Ireland...